These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9131796)

  • 1. Influence of ozone on the susceptibility of Escherichia coli K1 to the bactericidal action of serum.
    Jankowski S; Cisowska A; Doroszkiewicz W
    Folia Microbiol (Praha); 1996; 41(5):395-400. PubMed ID: 9131796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
    Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
    Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
    Cisowska A; Jankowski S
    Folia Microbiol (Praha); 2004; 49(4):471-8. PubMed ID: 15530015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Escherichia coli with capsular antigen K1 isolated from urinary tract infection on the joint action of cefotaxime and normal human serum.
    Jankowski S; Franiczek R
    Nephron; 1994; 68(4):519-20. PubMed ID: 7870242
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.
    Cisowska A; Bugla-Płoskońska G
    Folia Microbiol (Praha); 2014 Jan; 59(1):37-43. PubMed ID: 23794053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunization with Escherichia coli K1 antigen on the course of experimental infection of the urinary tract of the rat.
    Straube E; Nimmich W; Broschewitz U; Naumann G; Hacker K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):408-19. PubMed ID: 3314264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
    Cross AS; Gemski P; Sadoff JC; Orskov F; Orskov I
    J Infect Dis; 1984 Feb; 149(2):184-93. PubMed ID: 6199436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic bactericidal effect of cephalexin and normal cord serum (NCS) against Escherichia coli K1 strains isolated from children with urinary tract infections (UTI).
    Cisowska A; Jankowski S; Doroszkiewicz W
    Acta Microbiol Pol; 1999; 48(4):381-3. PubMed ID: 10756721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes.
    Timmis KN; Boulnois GJ; Bitter-Suermann D; Cabello FC
    Curr Top Microbiol Immunol; 1985; 118():197-218. PubMed ID: 3902381
    [No Abstract]   [Full Text] [Related]  

  • 11. The susceptibility of gram-negative rods and their adaptive forms resistant to colistine to the bactericidal action of sera.
    Doroszkiewicz W; Cisowska A; Jankowski S; Koziorowski A; Murawski M
    Acta Microbiol Pol; 1998; 47(3):275-81. PubMed ID: 9990711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model.
    Verweij-van Vught AM; van den Bosch JF; Namavar F; Sparrius M; MacLaren DM
    J Med Microbiol; 1983 May; 16(2):147-55. PubMed ID: 6341596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
    Agüero ME; Cabello FC
    Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence and other phenotypic characteristics of urinary isolates of cysteine-requiring Escherichia coli.
    McIver CJ; Tapsall JW
    J Med Microbiol; 1995 Jan; 42(1):39-42. PubMed ID: 7739023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Bortolussi R; Ferrieri P; Björkstén B; Quie PG
    Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
    Allen PM; Roberts I; Boulnois GJ; Saunders JR; Hart CA
    Infect Immun; 1987 Nov; 55(11):2662-8. PubMed ID: 3312006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections.
    Olling S; Hanson LA; Holmgren J; Jodal U; Lincoln K; Lindberg U
    Infection; 1973; 1(1):24-8. PubMed ID: 4594781
    [No Abstract]   [Full Text] [Related]  

  • 18. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia.
    Bonacorsi S; Houdouin V; Mariani-Kurkdjian P; Mahjoub-Messai F; Bingen E
    J Clin Microbiol; 2006 Mar; 44(3):1156-8. PubMed ID: 16517919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum response of Escherichia coli strains causing dyspepsia and urinary tract infection: relation to alpha-hemolysin production and O type.
    Siegfried L; Kmetová M; Janigová V; Sasinka M; Takácová V
    Infect Immun; 1995 Nov; 63(11):4543-5. PubMed ID: 7591101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.